Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
- Authors: Zaytseva N.V1, Shamkhalova M.S.1
-
Affiliations:
- Issue: No 16 (2014)
- Pages: 80-85
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/287425
- ID: 287425
Cite item
Open Access
Access granted
Abstract
Lifestyle modification, which is the first step in the treatment of type 2 diabetes mellitus, even in case of simultaneous beginning of therapy with metformin, often does not lead to the achievement of carbohydrate metabolism control. Glimepiride, a representative of the third generation sulfonylureas, is one of the drugs of choice for the enhancement of antihyperglicemic therapy. The article presents the results of open multicenter observational study on the efficacy and safety of combined use of metformin and glimepiride, allows to significantly improve the status of carbohydrate metabolism in patients with type 2 diabetes mellitus. This therapy is safe due to the low risk of hypoglycaemia, lack of side effects and adverse effects on body weight.
Full Text
References
- Дедов И.И., Шестакова М.В. Сахарный диабет. Диагностика, лечение, профилактика. М., 2011.
- Дедов И.И., Шестакова М.В., Аметов А.С., Анциферов М.Б., Галстян Г.Р., Майоров А.Ю., Петунина Н.А., Сухарева О.Ю. Консенсус совета экспертов Российской ассоциации эндокринологов по инициации и интенсификации сахароснижающей терапии у больных сахарным диабетом 2 типа. Сахарный диабет. 2011; (4): 6-17.
- Дедов И.И., Шестакова М.В. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. 6-й вып. М., 2013.
- Inzucchi S.E., Bergenstal R.M., Buse J.B., et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012; 35: 1364-79.
- International Diabetes Federation, 2012, Clinical Guidelines Task Force. Global Guideline for Type 2 Diabetes.
- American Diabetes Association (ADA). Standards of medical care in diabetes - 2014. Diabetes Care. 2014; 37(Suppl 1): S14-80.
- Редакционная коллегия журнала «Сахарный диабет». Результаты исследования ACCORD-EYE. Сахарный диабет. 2010; (2).
- Müller G., Hartz D., Pünter J., et al. Differential interaction of glimepiride and glibenclamide with the β-cell sulfonylurea receptor: i. Binding characteristics. Biochim. Biophys. Acta. 1994; 1191: 267-77.
- Charpentier G., Fleury F., Kabir M., et al. improved glycaemic control by addition of glimepiride to metformin monotherapy in type 2 diabetic patients. Diabet Med. 2001; 18: 828-34.
- Pareek A., et al. Evaluation of Efficacy and Tolerability of Glimepiride and Metformin Combination: A Multicentric Study in Patients with Type-2 Diabetes Mellitus, Uncontrolled on Monotherapy with Sulfonylurea or Metformin. Am. J. Therapeutics. 2013; 20(1): 14-47.
Supplementary files
